February 15, 2018 /

Positive Data from Summit’s PhaseOUT DMD Ezutromid Clinical Trial (February 2018)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Positive Data from Summit’s PhaseOUT DMD Ezutromid Clinical Trial (February 2018)

Parent Project Muscular Dystrophy and Action Duchenne hosted a webinar update on February 7, 2018 on the recent report that Summit has announced positive 24-week interim results from the open-label Phase 2 proof of concept clinical trial, PhaseOut DMD.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo